Mwandishi:
Mhariri:
Imeboreshwa;
ULY CLINIC
ULY CLINIC
27 Oktoba 2026, 13:25:33
Sickle cell disease: acute severe anaemia and acute splenic sequestration
Sickle cell disease: acute severe anaemia and acute splenic sequestration
Chanzo: National Sickle Cell Disease Management Guidelines, Ministry of Health Tanzania. Toleo: 2nd edition, June 2026. Mwongozo wa Taifa (supporting guideline). The STG 2026 article "Acute anaemia in sickle cell disease" remains the main reference.
Acute severe anaemia
Definition: haemoglobin below 5 g/dL, OR a recent acute drop in Hb of 2 g/dL or more below the steady state, OR acutely symptomatic anaemia (tachycardia, tachypnoea, tender hepatomegaly).
Possible causes
Infection, e.g. malaria or bacterial infection.
Splenic sequestration.
Haemolysis (jaundice, intercurrent illness or infection, high reticulocyte count).
Aplastic crisis due to parvovirus B19 (low reticulocyte count).
Bleeding.
Investigations
Immediately: blood grouping and cross-match of 10–15 mL/kg packed red cells.
Full blood count, reticulocyte count, creatinine, electrolytes, haptoglobin, bilirubin, LDH and ALT.
Urine microscopy for red blood cells and dipstick for urobilinogen.
Blood and urine cultures if febrile or there are signs of infection.
Malaria test.
Table 1. Laboratory pattern: haemolysis compared with aplastic crisis (national guideline)
Cause | Expected results |
Haemolysis | High reticulocyte count, high unconjugated bilirubin, high LDH, urine urobilinogen present, low haptoglobin |
Aplastic crisis (parvovirus B19) | Low reticulocyte count, normal bilirubin and LDH |
Management
Place an IV cannula and collect blood for investigations.
Immediately transfuse packed red blood cells 10–15 mL/kg over 4 hours if symptomatic or Hb is below 5 g/dL.
Treat the underlying cause where applicable.
Repeat the transfusion if the control Hb is below 5 g/dL or the patient is still symptomatic.
Assess and document the size of the liver and spleen.
⚠ Tofauti na STG 2026: STG 2026 transfuses packed red cells 10 mL/kg over 4 hours and defines the acute drop as more than 2 g/dL; the national guideline gives 10–15 mL/kg over 4 hours and a drop of 2 g/dL or more, and adds haptoglobin and urine tests to tell haemolysis from aplastic crisis.
Acute splenic sequestration
Splenic sequestration is a sudden enlargement of the spleen caused by trapping of a large part of the blood volume, with a rapid fall in haemoglobin and haematocrit, hypovolaemia and thrombocytopenia. It is most common in infants and children and tends to recur. Hepatic sequestration can also occur, usually in children older than 4 years.
Symptoms and signs
Pallor, lethargy, hypotension, tachycardia, hypovolaemic shock.
Abdominal pain or tenderness.
Abdominal distension with a tender, enlarged spleen.
Investigations
Blood grouping and cross-match.
Full blood count, reticulocyte count, electrolytes, creatinine, ALT, LDH; consider blood cultures and malaria test.
Management
Place an IV cannula and take blood for investigations.
Immediately give a 20 mL/kg normal saline bolus while waiting for blood; repeat the bolus if needed.
Transfuse 5–7.5 mL/kg over 3–4 hours (50% of the usual transfusion volume), because trapped blood returns to the circulation as the spleen shrinks.
Give oxygen if needed and analgesics if needed.
Check Hb 2 hours after the transfusion and consider a repeat transfusion.
Monitor SpO2, respiratory rate, pulse and blood pressure at least every 30 minutes.
Monitor the spleen size hourly for 12–24 hours until it starts to shrink.
Therapeutic splenectomy is indicated after more than 2 episodes of sequestration.
Acute splenic sequestration is life-threatening and may need high dependency care. There is a high risk of developing acute chest syndrome.
Imeandikwa:
27 Oktoba 2026, 13:23:58
Rejea za mada:
1. Ministry of Health Tanzania. National Sickle Cell Disease Management Guidelines, 2nd edition. June 2026. Part II, sections 4–5: Acute severe anaemia and acute splenic sequestration (pages 15–16).
2. Ministry of Health Tanzania. STG-NEMLIT 7th edition, 2026: Acute anaemia in sickle cell disease.
